Press Release | Association for Accessible Medicines

Apr 1, 2022 | Rachel Schwartz

HHS Finds Biosimilars Use Results in “Significant Spending Reduction” For Medicare and Its Beneficiaries

Dr. Robert Califf

Feb 15, 2022 | Rachel Schwartz

AAM Statement on the Confirmation of Robert Califf to Lead FDA

Academy of Managed Care Pharmacy (AMCP)

Feb 15, 2022 | Rachel Schwartz

Academy of Managed Care Pharmacy Named AAM’s 2022 Champion of Access

AAM board room

Feb 14, 2022 | Rachel Schwartz

Chirag Patel Named Chair of the Association for Accessible Medicines Board of Directors

AAM board room

Feb 14, 2022 | Rachel Schwartz

AAM Announces 2022 Board of Directors

AAM Lobby

Feb 14, 2022 | Rachel Schwartz

AAM Announces 2022 Associate Members

Team of inspectors

Feb 2, 2022 | Rachel Schwartz

AAM Statement on FDA User Fee Reauthorization

AAM Statement on Avalere Report

Jan 24, 2022 | Rachel Schwartz

Avalere Analysis Finds Medicare Part D Patients Continue to Pay More for Generics

Doesn't Add Up patient photo

Nov 19, 2021 | Rachel Schwartz

Association for Accessible Medicines Warns Build Back Better Act Threatens Patient Access

Dr. Robert Califf

Nov 12, 2021 | Rachel Schwartz

AAM Statement on the Nomination of Dr. Robert Califf to Lead FDA

Nov 10, 2021 | Rachel Schwartz

Paula Witt Joins AAM as Senior Manager, State Government Affairs

Misguided Drug Pricing Reform

Nov 2, 2021 | Rachel Schwartz

AAM Opposes Latest Prescription Drug Reform Framework